Wendall Wierenga, Director at CYTOKINETICS INC (CYTK), sold 12,040 shares at $32.02 ($386K) on 2023-08-21, disclosed to the SEC on 2023-08-21.
Scheduled sale ($386k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.02 | 6,020 | $193K | 50.0% |
| 2 | $32.02 | 6,020 | $193K | 50.0% |
| Total | $32.02 avg | 12,040 | $386K | 100% |
| Filing → |
| CYTK | SELL | 2024-11-26 | $37K | — | Filing → |
| CYTK | SELL | 2024-10-31 | $233K | — | Filing → |
| CYTK | SELL | 2023-12-27 | $368K | — | Filing → |